2021 annual financial data

Vivos Therapeutics, Inc. 2021 Net margin

Vivos Therapeutics, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was -120.15%.

Operating income was -19,471,000 USD and net income was -20,288,000 USD.
Operating cash flow was -15,735,000 USD.

Get free Vivos Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
16,885,000 USD
Operating income
-19,471,000 USD
Net income
-20,288,000 USD
Operating cash flow
-15,735,000 USD